Other

I2 Pharmaceuticals, Inc.

The University of New Mexico

Michael D Horowitz

Ramesh Bhatt

Lawrence C Horowitz

Pamela K Foreman

Michael Frank Erasmus

Charles H Hannum

Li Xu

Arun K Kashyap

Aaron L Kurtzman

Stuart S Winter

Phil Kobel

Sihong Zhou

Ryann E O'Neil

Bridget S Wilson

Medini Gore

Robin M Horowitz

This disclosure describes the identification of pre-B Cell Receptor (pre-BCR) antagonists and the use of pre-BCR antagonists as a targeted therapy. The compositions and methods generally involve a composition that includes a pre-B cell receptor (pre-BCR) antagonist and is engineered for expression as a T cell chimeric receptor. In some embodiments, the pre-BCR antagonists can include an anti-pre-BCR antibody.

Anti-pre-BCR antagonists and methods

Embodiments concern constructs comprising surrogate light chain sequences. In particular, embodiments concern constructs that can bind to ErbB3 and aspects relating to such constructs.

Sur-binding proteins against ERBB3

Embodiments concern constructs comprising surrogate light chain sequences. In particular, embodiments concern constructs that can bind to DR4 and/or DR5 and aspects relating to such constructs and their use.

Surrogate binding proteins which bind DR4 and/or DR5

A feminine hygiene cabinet which includes a plurality of compartments which are to contain a quantity of different types of feminine hygiene products. This cabinet is designed to be located within a conventional toilet facility and is designed to connect with a conventional toilet paper dispenser so that the cabinet will always be abuttingly located against a wall within the toilet facility regardless of variances in the installation of the toilet paper dispenser within the toilet facility.

Supporting bracket for a feminine hygiene cabinet

Growing community of inventors

Thousand Oaks, CA, United States of America

Michael D Horowitz